Glanbia Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NESN | Nestlé | Outperform |
11
|
CHF93.30 | CHF115.58 | 17.90% | 13 | CHF244.57B |
| KO | Coca Cola | Outperform |
18
|
$62.09 | $65.84 | 9.52% | 4 | $267.48B |
| PEP | PepsiCo | Outperform |
18
|
$179.27 | $187.26 | 3.20% | 7 | $246.46B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.23 | $118.92 | 19.93% | 7 | $181.32B |
| ULVR | Unilever PLC | Hold |
8
|
£43.12 | £50.61 | 18.60% | 12 | £107.86B |
| GSK | GSK | Outperform |
12
|
£17.78 | £17.30 | 12.20% | 12 | £72.51B |
| 500696 | Hindustan Unilever | Outperform |
10
|
Rp2.38k | Rp2.75k | 6.19% | 1 | Rp5.59T |
| BAS | BASF | Outperform |
12
|
48.44€ | 49.50€ | 15.61% | 2 | 43.23€B |
| GIVN | Givaudan | Hold |
14
|
CHF4.24k | CHF3.14k | -8.00% | 8 | CHF39.11B |
| BN | Danone | Outperform |
11
|
59.24€ | 55.47€ | 8.04% | 2 | 38.11€B |
| LONN | Lonza Group | Buy |
16
|
CHF512.00 | CHF516.89 | 17.19% | 8 | CHF36.92B |
| GIS | General Mills Inc | Hold |
18
|
$69.09 | $68.63 | 3.49% | 13 | $39.00B |
| DSFIR | DSM-Firmenich | Outperform |
18
|
105.85€ | 114.60€ | 14.31% | 0 | 28.08€B |
| NZYM B | Novozymes A/S | Outperform |
18
|
kr425.00 | kr365.54 | 5.88% | 4 | kr197.46B |
| IFF | International Flavors & Fragra... | Outperform |
15
|
$94.47 | $84.46 | 2.15% | 17 | $24.12B |
| CELH | Celsius Holdings | Outperform |
13
|
$91.71 | $68.64 | 0.32% | 5 | $21.37B |
| K | Kellanova | Hold |
13
|
$61.33 | $59.19 | 1.09% | 10 | $20.97B |
| MKC | McCormick & Company | Hold |
12
|
$72.15 | $72.03 | 3.95% | 1 | $19.20B |
| SY1 | Symrise | Outperform |
18
|
105.50€ | 106.97€ | 6.16% | 5 | 14.76€B |
| DABUR | Dabur India | Outperform |
18
|
Rp559.95 | Rp607.25 | 6.62% | 27 | Rp979.58B |
| CHR | Chr. Hansen Holding A/S | - |
16
|
kr549.60 | kr71.11 | -100.00% | 0 | kr72.33B |
| BARN | Barry Callebaut | Outperform |
18
|
CHF1.59k | CHF1.88k | -2.58% | 0 | CHF8.26B |
| SMPL | Simply Good Foods Co-The | Outperform |
15
|
$37.12 | $40.58 | 9.11% | 1 | $3.76B |
| GRG | Greggs | Outperform |
18
|
£28.62 | £32.27 | 14.61% | 0 | £2.82B |
| TATE | Tate & Lyle | Outperform |
16
|
£7.12 | £8.58 | 20.08% | 2 | £2.83B |
| SXT | Sensient Technologies | Buy |
18
|
$74.55 | $72.00 | 5.97% | 1 | $3.23B |
| BVIC | Britvic | Outperform |
18
|
£9.85 | £9.82 | 5.58% | 8 | £2.52B |
| CWK | Cranswick | Buy |
18
|
£44.00 | £44.24 | 10.23% | 9 | £2.37B |
| FCG | Fonterra Co-operative Group | - |
16
|
$2.21 | $0.00 | -100.00% | 0 | $4.19B |
| ARYN | ARYZTA | Buy |
10
|
CHF1.81 | CHF2.23 | 23.20% | 2 | CHF1.73B |
| PFD | Premier Foods | Buy |
16
|
£1.74 | £1.65 | 14.94% | 5 | £1.46B |
| CRBN | Corbion N.V. | Outperform |
14
|
21.00€ | 24.42€ | 19.05% | 5 | 1.21€B |
| HFG | Hilton Food Group | Buy |
16
|
£9.37 | £8.91 | 9.93% | 1 | £820.76M |
| GNC | Greencore Group | Outperform |
15
|
£1.62 | £1.04 | -13.58% | 4 | £763.42M |
| HLF | Herbalife | Outperform |
16
|
$10.86 | $17.90 | -7.92% | 4 | $937.70M |
| BAKK | Bakkavor Group | Buy |
18
|
£1.35 | £1.07 | -8.89% | 1 | £695.58M |
| CCR | C&C Group | Buy |
6
|
£1.71 | £2.38 | 30.41% | 3 | £671.62M |
| BAG | A.G. BARR p.l.c. | Buy |
18
|
£5.98 | £5.97 | 11.71% | 3 | £633.70M |
| NICL | Nichols | Outperform |
16
|
£10.40 | £11.57 | 15.87% | 0 | £368.92M |
| FSTA | Fuller, Smith & Turner P.L.C. | Hold |
13
|
£7.00 | £7.20 | -5.71% | 3 | £353.95M |
| MED | Medifast | Hold |
18
|
$22.76 | $69.50 | 9.84% | 2 | $277.33M |
| RELV | Reliv' International | - |
0
|
$6.00 | $21.00 | -100.00% | 0 | $5.55M |
| 542910 | Valencia Nutrition | - |
0
|
Rp78.00 | Rp0.00 | -100.00% | 0 | Rp76.52M |
| ERGO | Entia Biosciences | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| MSLP.Q | MusclePharm | - |
0
|
$0.00 | $1.65 | 0.00% | 0 | $0.00M |